Jiang et al. [40] demonstrated that miR-491 involved in arsenic trioxide-induced antiangiogenesis in HCC via inhibiting the TGF-β/smad3/NF-κB signaling pathway. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.